Valuation: Universal Vision Biotechnology Co., Ltd.

Market Cap 11.86B 366M 318M 297M 272M 515M 34.84B 521M 3.5B 1.37B 17.41B 1.38B 1.35B 57.7B P/E 2026 *
10.4x
P/E 2027 * -
Enterprise Value 11.86B 366M 318M 297M 272M 515M 34.84B 521M 3.5B 1.37B 17.41B 1.38B 1.35B 57.7B EV / Sales 2026 *
2.79x
EV / Sales 2027 * 2.67x
Free-Float
47.64%
Yield 2026 *
5.74%
Yield 2027 * -
05-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-04 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 22, 2026 CI
11-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 21, 2025 CI
24-11-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-09 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024 CI
1 day+2.94%
1 week+2.94%
Current month+5.66%
1 month-1.06%
3 months+1.45%
6 months-0.71%
Current year-4.11%
1 week 131
Extreme 131
140
1 month 130.5
Extreme 130.5
148
Current year 122
Extreme 122
154
1 year 122
Extreme 122
214.5
3 years 122
Extreme 122
365.09
5 years 122
Extreme 122
432.08
10 years 18.64
Extreme 18.643305
432.08
Manager TitleAgeSince
Chief Executive Officer - 2010-01-31
Director of Finance/CFO - 2016-03-31
President - -
Director TitleAgeSince
Chairman - 2012-06-27
Director/Board Member - 2003-06-01
Director/Board Member 66 2012-06-27
Change 5-day change 1-year change 3-year change Capi.($)
+2.94%+2.94%-30.86%-61.50% 356M
+0.62%+3.79%-32.25%-2.38% 90.25B
-0.86%-0.56%-19.52%-20.73% 34.47B
-0.65%+2.09%+7.23%-23.46% 14.57B
+0.91%+3.25% - - 10.37B
+6.81%+22.40%-18.19%+616.90% 2.08B
-0.78%+5.26%-40.88%-66.26% 1.53B
-0.13%+8.48%-32.60%-27.46% 895M
+3.69%+17.16%+20.51%+6.16% 867M
+1.56%-0.40%+47.90%-26.04% 815M
Average +1.46%+4.56%-10.96%+43.91% 15.62B
Weighted average by Cap. +0.31%+1.68%-24.42%-1.02%

Financials

2026 *2027 *
Net sales 4.25B 131M 114M 106M 97.63M 185M 12.49B 187M 1.25B 490M 6.24B 493M 482M 20.68B 4.44B 137M 119M 111M 102M 193M 13.04B 195M 1.31B 512M 6.52B 515M 504M 21.6B
Net income 1.14B 35.26M 30.62M 28.55M 26.22M 49.6M 3.35B 50.14M 337M 132M 1.68B 132M 130M 5.56B -
Net Debt - -
Logo Universal Vision Biotechnology Co., Ltd.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Employees
401
Date Price Change Volume
26-08-04 NT$140.00 +2.94% 365,703
26-08-04 NT$136.00 +2.26% 271,286
26-08-03 NT$133.00 +0.38% 200,432
26-07-31 NT$132.50 -0.75% 309,187
26-07-30 NT$133.50 -0.37% 222,421
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
136.00TWD
Average target price
150.00TWD
Spread / Average Target
+10.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3218 Stock